Rivastigmine Actavis
Capsule, hard
Compare
|
EU/1/11/693/001-004
Actavis Group hf
|
SPC
PIL
IPAR
|
Rivastigmine Actavis
Capsule, hard
Compare
|
EU/1/11/693/005-008
Authorised: 16/06/2011
Actavis Group hf
|
SPC
PIL
IPAR
|
Rivastigmine Actavis
Capsule, hard
Compare
|
EU/1/11/693/009-012
Authorised: 16/06/2011
Actavis Group hf
|
SPC
PIL
IPAR
|
Rivastigmine Actavis
Capsule, hard
Compare
|
EU/1/11/693/013-016
Authorised: 16/06/2011
Actavis Group hf
|
SPC
PIL
IPAR
|
RIVASTIGMINE ACTAVIS
Transdermal Patch
Compare
|
EU/1/11/693/017-20
Authorised: 17/04/2013
Actavis Group PTC ehf
|
SPC
PIL
IPAR
|
RIVASTIGMINE ACTAVIS
Transdermal Patch
Compare
|
EU/1/11/693/021-24
Authorised: 17/04/2013
Actavis Group PTC ehf
|
SPC
PIL
IPAR
|
Rivastigmine Hexal
Capsule, hard
Compare
|
EU/1/09/589/13-16
Hexal AG
|
SPC
PIL
IPAR
|
Rivastigmine Hexal
Capsule, hard
Compare
|
EU/1/09/589/1-4
Hexal AG
|
SPC
PIL
IPAR
|
Rivastigmine Hexal
Capsule, hard
Compare
|
EU/1/09/589/5-8
Hexal AG
|
SPC
PIL
IPAR
|
Rivastigmine Hexal
Capsule, hard
Compare
|
EU/1/09/589/9-12
Hexal AG
|
SPC
PIL
IPAR
|
Rivastigmine Hexal (120 ml)
Oral solution
Compare
|
EU/1/09/589/018
Hexal AG
|
SPC
PIL
IPAR
|
Rivastigmine Hexal (50 ml)
Oral solution
Compare
|
EU/1/09/589/017
Hexal AG
|
SPC
PIL
IPAR
|
Rivastigmine Sandoz
Capsule, hard
Compare
|
EU/1/09/599/13-16
Sandoz Pharmaceuticals GmbH
|
SPC
PIL
IPAR
|
Rivastigmine Sandoz
Capsule, hard
Compare
|
EU/1/09/599/1-4
Sandoz Pharmaceuticals GmbH
|
SPC
PIL
IPAR
|
Rivastigmine Sandoz
Capsule, hard
Compare
|
EU/1/09/599/5-8
Sandoz Pharmaceuticals GmbH
|
SPC
PIL
IPAR
|
Rivastigmine Sandoz
Capsule, hard
Compare
|
EU/1/09/599/9-12
Sandoz Pharmaceuticals GmbH
|
SPC
PIL
IPAR
|
Rivastigmine Sandoz (120 ml)
Oral solution
Compare
|
EU/1/09/599/018
Sandoz Pharmaceuticals GmbH
|
SPC
PIL
IPAR
|
Rivastigmine Sandoz (50 ml)
Oral solution
Compare
|
EU/1/09/599/017
Sandoz Pharmaceuticals GmbH
|
SPC
PIL
IPAR
|
Rivotril 0.5 mg Tablets
Tablet
Compare
|
PA2239/020/001
Authorised: 01/04/1977
CHEPLAPHARM Arzneimittel GmbH
|
SPC
PIL
|
Rixathon
Concentrate for solution for infusion
Compare
|
EU/1/17/1185/001-002
Authorised: 15/06/2017
Sandoz GmbH
|
SPC
PIL
IPAR
EdM
|